Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.3 USD | -1.10% |
|
-3.66% | +16.20% |
01:47pm | Stocks to watch as Biden and Trump vie for presidency | RE |
07-01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.20% | 323B | |
+55.99% | 816B | |
+39.28% | 634B | |
-7.51% | 351B | |
+7.25% | 293B | |
+13.26% | 238B | |
+0.74% | 222B | |
+13.28% | 218B | |
+8.05% | 167B | |
-2.69% | 158B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat